MENSNasdaqPharmaceutical Preparations

Jyong Biotech Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026

$1.93+0.09 (+4.89%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Jyong Biotech has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Jyong Biotech filed with the SEC

Jan 9, 2026, 4:30 PM ET
UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2025, AND UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024
EX-99.1 to Form 6-K
Jun 18, 2025, 5:54 PM ET
PRESS RELEASE ON PRICING OF THE COMPANY'S INITIAL PUBLIC OFFERING
EX-99.1 to Form 6-K
Jun 18, 2025, 5:54 PM ET
PRESS RELEASE ON CLOSING OF THE COMPANY'S INITIAL PUBLIC OFFERING
EX-99.2 to Form 6-K